RNA sequencing (RNAseq) analysis of TILs derived from wild-type and Nr2f6−/− tumor-bearing mice collected at d14 after B16-OVA tumor cell injection clearly demonstrated that the NR2F6- and PD-1-mediated immune-suppressive pathways are mechanistically distinct (Fig. 3a). Here, NR2F6 is linked to neoplasm.